MedPath

Comparing how two different doses of an additive to bupivacaine heavy modifies the duration of action when used in lower limb surgeries

Phase 3
Conditions
Health Condition 1: S899- Unspecified injury of lower leg
Registration Number
CTRI/2022/01/039545
Lead Sponsor
Dr Ashik Sreekumar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients from age 18 to 65 belonging to ASA grade 1, 2 or 3 undergoing lower limb surgeries

Exclusion Criteria

Contraindications of spinal Anesthesia such as Local infection, raised intra cranial tension, coagulopathy , valvular heart disease

Known allergy to the study drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Time of onset of sensory block. <br/ ><br>2) Maximum height of sensory block. <br/ ><br>3) Duration of sensory block as regression to L1. <br/ ><br>4) Time of onset of motor block. <br/ ><br>5) Duration of motor block. <br/ ><br>6) Duration of post operative analgesia. <br/ ><br>Timepoint: Sensory block will be tested every 2 min till maximum height of sensory level, Thereafter every 20 min till the block regression to L1 level. <br/ ><br> Motor block will be tested every 2 mins using Bromage scale till starting of surgery,Thereafter every 20 mins in the post op period till complete recovery (grade 0) and duration of motor block will be noted.
Secondary Outcome Measures
NameTimeMethod
Intra operative hemodynamic parameters eg Heart rate & Mean Blood Pressure <br/ ><br>Side effects such as nausea vomiting, pruritus, urinary retention and respiratory depression <br/ ><br>Timepoint: Every 2 min for the first 20 min and then every 10 min till the block regression to L1, post operative analgesia every 30 min for the first 2 hours and 2 hourly thereafter.
© Copyright 2025. All Rights Reserved by MedPath